Evaluation and Management of Microscopic Hematuria

Definition and Clinical Significance

Microscopic hematuria is definitively diagnosed at ≥3 RBCs/HPF on microscopic examination of properly collected urine specimens, according to the American Academy of Family Physicians 3, 1, 2
A finding of 25 RBCs/HPF substantially exceeds this diagnostic threshold and represents clinically significant hematuria that cannot be dismissed as normal variation, as stated by the American Urological Association 3, 1
The degree of hematuria (25 RBCs/HPF) places this patient in a higher risk category for underlying pathology, as the AUA/SUFU guidelines stratify risk partly based on RBC count, with 3-10 RBCs/HPF being low risk and higher counts conferring increased risk 1

Malignancy accounts for 2.6-4% of microscopic hematuria cases overall, but risk increases substantially with age >35-40 years, male gender, smoking history, and occupational chemical exposure, according to the American Family Physician 4, 3
Urinary tract infection is a common cause and should be excluded with urine culture before proceeding with extensive evaluation, as recommended by the American Family Physician 4, 3
Urolithiasis (kidney or ureteral stones) frequently presents with microscopic hematuria, as noted by the American Family Physician 4

Risk factors for malignancy, such as smoking history, age >40 years, and occupational exposure, should be elicited, as recommended by the American Family Physician 4, 3, 7
Symptoms suggesting infection, such as dysuria, urgency, frequency, fever, and suprapubic pain, should be assessed, according to the American Family Physician 4, 1
The American Academy of Family Physicians recommends assessing for proteinuria, as significant proteinuria indicates renal parenchymal disease 4, 5
The American Urological Association suggests measuring serum creatinine and eGFR to assess renal function, as elevated creatinine suggests renal parenchymal disease 4, 1

The American Family Physician states that features suggesting glomerular origin include >80% dysmorphic RBCs, RBC casts, significant proteinuria, and elevated serum creatinine 4, 5
The American Urological Association recommends that features suggesting non-glomerular origin include <17% dysmorphic RBCs, absence of proteinuria, and normal renal function 5

The American Urological Association recommends multiphasic CT urography as the preferred imaging modality for evaluating the upper urinary tract, as it provides comprehensive assessment in a single study without need for additional imaging 1, 2, 7
Cystoscopy is mandatory for all patients with microscopic hematuria who are ≥35 years old or have risk factors for bladder cancer, according to the American Urological Association 4, 3, 1, 7

The American Urological Association states that patients on anticoagulation/antiplatelet therapy should undergo the same complete evaluation as patients not on these medications, as these medications unmask rather than cause bleeding 1, 7
The American Family Physician recommends treating urinary tract infection appropriately and repeating urinalysis 6 weeks after treatment completion, as infection can cause hematuria 4, 3

The American Family Physician suggests repeating urinalysis, blood pressure measurement, and assessment for proteinuria at 6, 12, 24, and 36 months, as patients with isolated hematuria may have structural glomerular abnormalities 4, 5
The American Urological Association recommends considering repeat anatomic evaluation (imaging and/or cystoscopy) within 3-5 years if hematuria persists or recurs, as stated by the Praxis Medical Insights 7